UBS analyst Matt Miksic reiterates Buy rating and raises price target on NuVasive Inc. (NASDAQ: NUVA) to $82 (from $71) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE